HIV

ViiV Healthcare announces FDA approval of an expanded indication for Dovato (dolutegravir/lamivudine), a complete two-drug regimen for virologically suppressed adults with HIV-1

By
1 Mins read
94
0
Share
Reading Time: < 1 minute

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced Read More

94
0
Share
Related posts
HIV

US approves life-saving organ transplants between people with HIV, removing ‘unnecessary barriers’

By
1 Mins read
Reading Time: < 1 minute People with HIV who need liver and kidney transplants can now receive organs from donors with HIV. Read More
HIV

'Huge relief' as new drug found to effectively prevent HIV infection

By
1 Mins read
Reading Time: < 1 minute A vaccination with the drug lenacapavir offers an effective protection against a HIV infection, according to newly published research from the pivotal…
HIV

HIV warning issued by UKHSA as diagnosis rate jumps by more than 30%

By
1 Mins read
Reading Time: < 1 minute Startling new data warns that HIV cases may be on the rise in England, serving as a ‘crucial reminder’ that we must safeguard…
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.